Cargando…

Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease

SIRT1 is an NAD(+)-dependent class III histone deacetylase that is abundantly expressed in the kidney, where it modulates gene expression, apoptosis, energy homeostasis, autophagy, acute stress responses, and mitochondrial biogenesis. Alterations in SIRT1 activity and NAD(+) metabolism are frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tovar-Palacio, Claudia, Noriega, Lilia G., Mercado, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837945/ https://www.ncbi.nlm.nih.gov/pubmed/35277012 http://dx.doi.org/10.3390/nu14030653

Ejemplares similares

SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure
por: Buonvicino, Daniela, et al.
Publicado: (2021)

Silibinin Restores NAD(+) Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
por: Salomone, Federico, et al.
Publicado: (2017)

Coordinated metabolic transitions and gene expression by NAD(+) during adipogenesis
por: Sánchez-Ramírez, Edgar, et al.
Publicado: (2022)

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats
por: Braidy, Nady, et al.
Publicado: (2011)

The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis
por: Podyacheva, Ekaterina, et al.
Publicado: (2023)

CERKL regulates autophagy via the NAD-dependent deacetylase SIRT1
por: Hu, Xuebin, et al.
Publicado: (2018)

The Role of the Unfolded Protein Response on Renal Lipogenesis in C57BL/6 Mice
por: Figueroa-Juárez, Elizabeth, et al.
Publicado: (2021)

Metabolic Characterization of a Sirt5 deficient mouse model
por: Yu, Jiujiu, et al.
Publicado: (2013)

Expression of Concern: Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats
Publicado: (2022)

NAD(+)-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
por: Cerutti, Raffaele, et al.
Publicado: (2014)

NAD(+) Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
por: Chanvillard, Lucie, et al.
Publicado: (2022)

β-lapachone ameliorates murine cisplatin nephrotoxicty – NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation
por: Lu, Christopher Y.
Publicado: (2014)

NAD(+) homeostasis in renal health and disease
por: Ralto, Kenneth M., et al.
Publicado: (2019)

CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD(+)/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats
por: Ogura, Yoshio, et al.
Publicado: (2020)

The NAD World 2.0: the importance of the inter-tissue communication mediated by NAMPT/NAD(+)/SIRT1 in mammalian aging and longevity control
por: Imai, Shin-ichiro
Publicado: (2016)

Vachellia farnesiana Pods or a Polyphenolic Extract Derived from Them Exert Immunomodulatory, Metabolic, Renoprotective, and Prebiotic Effects in Mice Fed a High-Fat Diet
por: Delgadillo-Puga, Claudia, et al.
Publicado: (2023)

Improvement Effect of Mitotherapy on the Cognitive Ability of Alzheimer’s Disease through NAD(+)/SIRT1-Mediated Autophagy
por: Yang, Xiaoxi, et al.
Publicado: (2023)

NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
por: Xie, Na, et al.
Publicado: (2020)

NAD(+) metabolism-based immunoregulation and therapeutic potential
por: Fang, Jiankai, et al.
Publicado: (2023)

Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease
por: Ryu, Woo‐In, et al.
Publicado: (2022)

The NAD(+)-dependent protein deacetylase activity of SIRT1 is regulated by its oligomeric status
por: Guo, Xiumei, et al.
Publicado: (2012)

Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD(+) and SIRT1
por: Ghosh, Nandini, et al.
Publicado: (2020)

NAD(+) Metabolism and Diseases with Motor Dysfunction
por: Lundt, Samuel, et al.
Publicado: (2021)

Dietary proanthocyanidins boost hepatic NAD(+) metabolism and SIRT1 expression and activity in a dose-dependent manner in healthy rats
por: Aragonès, Gerard, et al.
Publicado: (2016)

PGC1α-dependent NAD biosynthesis links oxidative metabolism to renal protection
por: Tran, Mei T., et al.
Publicado: (2016)

Polyphenols and Their Metabolites in Renal Diseases: An Overview
por: Guerreiro, Íris, et al.
Publicado: (2022)

Targeting NAD(+) Metabolism as Interventions for Mitochondrial Disease
por: Lee, Chi Fung, et al.
Publicado: (2019)

Cocoa Polyphenol Extract Inhibits Cellular Senescence via Modulation of SIRT1 and SIRT3 in Auditory Cells
por: Rivas-Chacón, Luz del Mar, et al.
Publicado: (2023)

Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in Mycobacterium tuberculosis
por: Sharma, Ritu, et al.
Publicado: (2023)

NAD+ cellular redox and SIRT1 regulate the diurnal rhythms of tyrosine hydroxylase and conditioned cocaine reward
por: Logan, Ryan W., et al.
Publicado: (2018)

NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1
por: Aguilar-Arnal, Lorena, et al.
Publicado: (2015)

NAD(+) Metabolism, Metabolic Stress, and Infection
por: Groth, Benjamin, et al.
Publicado: (2021)

SIRT3, a Mitochondrial NAD(+)-Dependent Deacetylase, Is Involved in the Regulation of Myoblast Differentiation
por: Abdel Khalek, Waed, et al.
Publicado: (2014)

The effect of 4-hexylresorinol administration on NAD+ level and SIRT activity in Saos-2 cells
por: Lee, In-Song, et al.
Publicado: (2021)

NAD Metabolism in Cancer Therapeutics
por: Yaku, Keisuke, et al.
Publicado: (2018)

Enzymology of extracellular NAD metabolism
por: Gasparrini, Massimiliano, et al.
Publicado: (2021)

Rev1 contributes to proper mitochondrial function via the PARP-NAD(+)-SIRT1-PGC1α axis
por: Fakouri, Nima Borhan, et al.
Publicado: (2017)

Role of PGC-1α in the Mitochondrial NAD(+) Pool in Metabolic Diseases
por: Koh, Jin-Ho, et al.
Publicado: (2021)

Polyphenols in Metabolic Diseases
por: Gasmi, Amin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_445o0tfag068fnmmj8ceuha19u